COM:KIORAPHARMA
Kiora Pharmaceuticals
- Stock
Last Close
3.30
22/11 21:00
Market Cap
10.11M
Beta: -
Volume Today
6.59K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 0.50 - | |||||||||||
average payables | 61.72K - | 289.82K 369.57% | 491.82K 69.70% | 914.91K 86.03% | 1.06M 15.76% | 384.87K 63.66% | 136.97K 64.41% | 322.53K 135.47% | 297.69K 7.70% | 584.44K 96.32% | 607.26K 3.90% | |
average receivables | 36.92K - | 30.23K 18.12% | 478.96K 1,484.39% | 493.21K 2.97% | 38.76K 92.14% | 21.06K 45.66% | 11.65K 44.70% | 47.92K 311.42% | 310.27K 547.52% | 951.30K 206.61% | 1.71M 79.91% | |
book value per share | -5.04K - | -4.05K 19.79% | 592.50 114.64% | -22.37 103.78% | -81.08 262.37% | 151.11 286.37% | 83.28 44.89% | 60.98 26.77% | 38.26 37.26% | 15.58 59.29% | 1.26 91.90% | |
capex per share | -0.75 - | -1.56 108.37% | -4.57 193.26% | -1.17 - | -0.26 77.27% | |||||||
capex to depreciation | -2.12 - | -1.92 9.58% | -7.02 265.76% | -4.01 - | -1.41 64.80% | |||||||
capex to operating cash flow | 0.00 - | 0.01 337.47% | 0.02 335.28% | 0.02 - | 0.01 67.92% | |||||||
capex to revenue | -0.02 - | -0.09 452.39% | -0.16 79.96% | -11.09 - | ||||||||
cash per share | 56.37 - | 14.44 74.39% | 817.11 5,560.02% | 246.91 69.78% | 328.45 33.03% | 135.35 58.79% | 47.49 64.91% | 10.33 78.25% | 32.58 215.40% | 8.14 75.00% | 0.51 93.78% | |
days of inventory on hand | 0.01 - | |||||||||||
days payables outstanding | 1.21K - | |||||||||||
days sales outstanding | 29.36 - | 21.21 27.74% | 4.07 80.80% | 0.66 83.79% | 2.75K 417,104.20% | |||||||
debt to assets | 2.93 - | 2.28 22.18% | 0.00 - | 0.00 61.93% | 0.00 70.61% | 0.01 2,413.64% | 0.02 187.86% | 0.01 51.46% | 0.01 2.33% | 0.01 31.18% | ||
debt to equity | -0.05 - | -0.07 51.49% | -0.09 - | -0.01 90.43% | 0.00 106.33% | 0.01 2,301.88% | 0.05 308.23% | 0.02 56.12% | 0.02 18.31% | 0.02 5.66% | ||
dividend yield | ||||||||||||
earnings yield | -0.12 - | -0.04 64.86% | -0.50 1,066.63% | -0.93 86.47% | -0.87 6.52% | -0.66 24.36% | -0.22 66.02% | -0.36 60.56% | -1.13 214.94% | -5.41 380.35% | -4.95 8.52% | |
enterprise value | 33.53M - | 44.68M 33.26% | 8.49M 80.99% | 10.79M 27.05% | 7.47M 30.81% | 8.50M 13.83% | 28.18M 231.53% | 21.81M 22.60% | 6.92M 68.29% | -3.35M 148.39% | 181.70K 105.43% | |
enterprise value over ebitda | -10.85 - | -18.17 67.46% | -1.27 93.00% | -0.81 36.41% | -0.51 36.52% | -0.80 54.87% | -4.15 421.98% | -2.67 35.59% | -0.65 75.66% | 0.29 144.22% | -0.02 107.32% | |
ev to operating cash flow | -11.34 - | -47.00 314.62% | -1.90 95.95% | -1.28 32.66% | -1.15 10.00% | -0.78 32.11% | -3.46 340.93% | -2.98 13.75% | -0.64 78.69% | 0.32 150.52% | -0.02 105.92% | |
ev to sales | 16.13 - | 18.33 13.64% | 5.14 71.93% | 10.49 103.97% | 1.81K 17,140.31% | |||||||
free cash flow per share | -332.69 - | -82.18 75.30% | -434.07 428.21% | -572.18 31.82% | -273.73 52.16% | -187.94 31.34% | -102.53 45.44% | -64.91 36.69% | -45.42 30.02% | -14.24 68.65% | -1.97 86.14% | |
free cash flow yield | -0.09 - | -0.02 75.30% | -0.26 1,056.67% | -0.59 121.58% | -0.43 27.12% | -0.67 57.99% | -0.26 62.02% | -0.33 28.67% | -0.75 128.47% | -4.15 452.05% | -3.78 9.00% | |
graham net net | -4.33K - | -3.57K 17.57% | 552.19 115.49% | -433.64 178.53% | -353.80 18.41% | 45.21 112.78% | 3.65 91.93% | -60.15 1,747.70% | -2.41 95.99% | -0.38 84.36% | -0.75 97.59% | |
graham number | 7.04K - | 3.74K 46.91% | 3.30K 11.67% | 675.47 79.53% | 1.01K 49.12% | 788.38 21.73% | 408.91 48.13% | 311.00 23.94% | 241.95 22.20% | 80.63 66.67% | 8.57 89.38% | |
income quality | 0.80 - | 0.61 23.71% | 0.53 13.23% | 0.63 18.60% | 0.49 22.38% | 1.00 104.97% | 1.15 14.55% | 0.90 21.30% | 0.66 26.56% | 0.77 15.60% | 0.76 0.52% | |
intangibles to total assets | 0 - | 0 | 0 | 0.56 Infinity% | 0.38 31.98% | 0.40 4.66% | 0.56 40.60% | 0.87 55.85% | 0.48 44.77% | 0.58 19.44% | 0.64 11.76% | |
interest coverage | -5.07 - | -5.57 10.00% | -3.45 38.07% | -48.53K 1,405,922.26% | -11.98K 75.31% | -10.43K 12.98% | -21.54K 106.58% | -1.96K 90.92% | -2.47K 26.41% | -1.43K 42.11% | -780.65 45.47% | |
interest debt per share | 296.81 - | 315.29 6.23% | 188.31 40.27% | 1.97 98.95% | 0.73 63.06% | 0.10 86.62% | 1.06 988.68% | 3.19 201.22% | 0.90 71.89% | 0.30 66.48% | 0.02 91.89% | |
inventory turnover | 62.42K - | |||||||||||
invested capital | -0.05 - | -0.07 51.49% | -0.09 - | -0.01 90.43% | 0.00 106.33% | 0.01 2,301.88% | 0.05 308.23% | 0.02 56.12% | 0.02 18.31% | 0.02 5.66% | ||
market cap | 32.00M - | 41.64M 30.12% | 16.89M 59.45% | 14.40M 14.74% | 15.26M 5.96% | 16.50M 8.14% | 31.87M 93.18% | 22.64M 28.98% | 14.56M 35.67% | 2.51M 82.75% | 2.53M 0.70% | |
net current asset value | -38.42M - | -41.21M 7.27% | 6.03M 114.63% | -5.91M 197.97% | -7.77M 31.61% | 3.13M 140.32% | 834.25K 73.38% | -6.35M 860.91% | 157.39K 102.48% | 410.01K 160.50% | -2.86M 798.57% | |
net debt to ebitda | -0.49 - | -1.24 150.19% | 1.26 201.78% | 0.27 78.50% | 0.54 98.15% | 0.75 39.72% | 0.54 27.32% | 0.10 81.44% | 0.72 612.44% | 0.50 29.96% | 0.27 45.99% | |
net income per share | -436.38 - | -153.35 64.86% | -817.01 432.76% | -906.30 10.93% | -556.17 38.63% | -182.81 67.13% | -89.24 51.19% | -70.50 21.00% | -68.00 3.54% | -18.55 72.72% | -2.58 86.07% | |
operating cash flow per share | -332.69 - | -82.18 75.30% | -434.07 428.21% | -571.43 31.65% | -272.18 52.37% | -183.37 32.63% | -102.53 44.09% | -63.75 37.83% | -45.16 29.16% | -14.24 68.47% | -1.97 86.14% | |
payables turnover | 0.30 - | |||||||||||
receivables turnover | 12.43 - | 17.21 38.40% | 89.64 420.96% | 553.02 516.96% | 0.13 99.98% | |||||||
research and ddevelopement to revenue | 12.58 - | 25.35 101.43% | 4.87 80.77% | 2.01 58.84% | 295.72 14,638.20% | |||||||
return on tangible assets | -5.60 - | -1.26 77.49% | -0.88 30.01% | -3.11 252.14% | -1.49 52.05% | -1.26 15.65% | -1.59 26.68% | -4.17 161.50% | -1.75 57.96% | -1.71 2.25% | -2.55 49.25% | |
revenue per share | 45.46 - | 17.15 62.28% | 27.94 62.96% | 33.78 20.87% | 0.11 99.69% | |||||||
roe | 0.09 - | 0.04 56.19% | -1.38 3,738.28% | 40.51 3,037.50% | 6.86 83.07% | -1.21 117.64% | -1.07 11.43% | -1.16 7.88% | -1.78 53.74% | -1.19 33.00% | -2.05 72.01% | |
roic | 0.09 - | 0.08 8.60% | -1.35 1,775.00% | 49.08 3,733.81% | 6.98 85.79% | -1.22 117.52% | -1.05 14.48% | -1.10 5.40% | -1.72 56.58% | -1.04 39.63% | -1.39 33.95% | |
sales general and administrative to revenue | 8.36 - | 11.38 36.13% | 2.69 76.38% | 1.64 38.97% | 386.33 23,453.34% | |||||||
shareholders equity per share | -5.04K - | -4.05K 19.79% | 592.50 114.64% | -22.37 103.78% | -81.08 262.37% | 151.11 286.37% | 83.28 44.89% | 60.98 26.77% | 38.26 37.26% | 15.58 59.29% | 1.26 91.90% | |
stock based compensation to revenue | 0.76 - | 2.14 179.71% | 0.53 75.20% | 0.32 40.10% | 60.03 18,818.65% | |||||||
tangible asset value | -38.29M - | -40.03M 4.54% | 6.09M 115.21% | -5.77M 194.76% | -7.37M 27.70% | 3.25M 144.19% | 965.50K 70.33% | -6.22M 743.74% | 528.76K 108.51% | 664.44K 25.66% | -2.70M 506.99% | |
tangible book value per share | -4.31K - | -3.46K 19.66% | 592.50 117.12% | -761.11 228.46% | -538.73 29.22% | 55.03 110.21% | 12.14 77.94% | -54.15 545.98% | 2.19 104.05% | 0.91 58.63% | -0.56 161.55% | |
working capital | -2.01M - | -4.81M 138.77% | 6.03M 225.45% | -3.15M 152.32% | -6.37M 102.10% | 4.61M 172.39% | 2.91M 36.94% | 37.82K 98.70% | 7.38M 19,415.53% | 4.41M 40.28% | 3.10M 29.59% |
All numbers in (except ratios and percentages)